Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism (ALTERNATIVE) Study

This observational study involves a collaboration between KPNC, KPSC and UCSF that will examine clinical and patient-centered outcomes (recurrent VTE, hemorrhage, treatment satisfaction, and quality of life) associated with different lengths of anticoagulation therapy after an initial 3-month treatment course in patients with venous thromboembolism and explore whether there are differences by type of oral anticoagulant.

0